Correlation Between AbbVie and CG Oncology,
Can any of the company-specific risk be diversified away by investing in both AbbVie and CG Oncology, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AbbVie and CG Oncology, into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AbbVie Inc and CG Oncology, Common, you can compare the effects of market volatilities on AbbVie and CG Oncology, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AbbVie with a short position of CG Oncology,. Check out your portfolio center. Please also check ongoing floating volatility patterns of AbbVie and CG Oncology,.
Diversification Opportunities for AbbVie and CG Oncology,
0.58 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between AbbVie and CGON is 0.58. Overlapping area represents the amount of risk that can be diversified away by holding AbbVie Inc and CG Oncology, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CG Oncology, Common and AbbVie is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AbbVie Inc are associated (or correlated) with CG Oncology,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CG Oncology, Common has no effect on the direction of AbbVie i.e., AbbVie and CG Oncology, go up and down completely randomly.
Pair Corralation between AbbVie and CG Oncology,
Given the investment horizon of 90 days AbbVie Inc is expected to under-perform the CG Oncology,. In addition to that, AbbVie is 1.04 times more volatile than CG Oncology, Common. It trades about -0.15 of its total potential returns per unit of risk. CG Oncology, Common is currently generating about -0.02 per unit of volatility. If you would invest 3,553 in CG Oncology, Common on September 1, 2024 and sell it today you would lose (78.00) from holding CG Oncology, Common or give up 2.2% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 95.45% |
| Values | Daily Returns |
AbbVie Inc vs. CG Oncology, Common
Performance |
| Timeline |
| AbbVie Inc |
| CG Oncology, Common |
AbbVie and CG Oncology, Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with AbbVie and CG Oncology,
The main advantage of trading using opposite AbbVie and CG Oncology, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AbbVie position performs unexpectedly, CG Oncology, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CG Oncology, will offset losses from the drop in CG Oncology,'s long position.| AbbVie vs. Tff Pharmaceuticals | AbbVie vs. Eliem Therapeutics | AbbVie vs. Inhibrx | AbbVie vs. Enliven Therapeutics |
| CG Oncology, vs. Patterson UTI Energy | CG Oncology, vs. Cheniere Energy Partners | CG Oncology, vs. Drilling Tools International | CG Oncology, vs. NRG Energy |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios |